Anulika Nikky Priddy, PA in East Orange, NJ - Pain Medicine

Anulika Nikky Priddy, PA is a Pain Medicine - Interventional Pain Medicine physician based in East Orange, New Jersey. Anulika Nikky Priddy is licensed to practice in New Jersey (license number 25MP00522600) and her current practice location is 310 Central Ave, East Orange, New Jersey. She can be reached at her office (for appointments etc.) via phone at (908) 425-6574.

NPI number for Anulika Nikky Priddy is 1518527415 and her current mailing address is 4518 Hudson Ave Apt 2, Union City, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1518527415.

Contact Information

	Anulika Nikky Priddy, PA
	310 Central Ave, East Orange, NJ 07018-2835
	(908) 425-6574
	Not Available

Physician's Profile

Full Name	Anulika Nikky Priddy
Gender	Female
Speciality	Pain Medicine - Interventional Pain Medicine
Location	310 Central Ave, East Orange, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1518527415
Provider Enumeration Date: 06/13/2019
Last Update Date: 06/13/2019

Medical Identifiers

Medical identifiers for Anulika Nikky Priddy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518527415	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0014X	Pain Medicine - Interventional Pain Medicine	25MP00522600 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anulika Nikky Priddy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Anulika Nikky Priddy, PA 4518 Hudson Ave Apt 2, Union City, NJ 07087-6318 Ph: () -	Anulika Nikky Priddy, PA 310 Central Ave, East Orange, NJ 07018-2835 Ph: (908) 425-6574

News Archive

Medrisk provides telerehabilitation for injured workers in hurricane affected areas

Hurricane Florence set records for rainfall from a hurricane in both North and South Carolina. Flooding has rendered many roads impassable and more flooding is expected. The hurricane caused approximately $44 billion in property damage and lost output according to Moody's Analytics, and repairs and cleanup will take months.

UT Southwestern receives $8 million NIH grant to study influence of brain and liver on inflammation

An $8 million grant from the National Institutes of Health will enable UT Southwestern Medical Center to investigate how fat tissue "talks" to the brain and the liver to promote inflammation-related disorders such as diabetes, heart disease and obesity.

Xenon gas shown to be safe in surgery and could help stop nervedamaging illnesses

Scientists have successfully conducted the first clinical trial giving xenon gas to patients undergoing coronary artery bypass grafting in order to safeguard against postoperative brain damage that can occur following this procedure.

Ingenuity Systems and Geospiza partner to enable seamless next-generation sequencing analysis workflow

Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Geospiza, Inc., the market leading developer of laboratory management and genetic analysis software, today announced a collaboration to enable a seamless next-generation sequencing analysis workflow. The companies will integrate their software products, GeneSifter® and IPA®, to enable researchers to obtain deep biological insights from their project samples through a rapid and reliable workflow to analyze and visualize next-generation sequencing data.

HRA Pharma launches its new generation emergency contraceptive in Europe

HRA Pharma (http://www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate, 30mg), its new generation emergency contraceptive, has been launched in France, Germany and the United Kingdom via local HRA teams. HRA Pharma will progressively launch ellaOne in all European countries over the coming months.

Anulika Nikky Priddy, PA - Pain Medicine in East Orange, NJ